Trial of Enhanced Neurostimulation for Anorexia
- Conditions
- Anorexia Nervosa
- First Posted Date
- 2023-03-28
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 70
- Registration Number
- NCT05788042
- Locations
- 🇦🇺
Northside Clinic, Sydney, New South Wales, Australia
SMART Health Pregnancy 2 - Intervention to Reduce Anaemia and Cardiometabolic Risk During Pregnancy and in the First Year Following Birth
- Conditions
- Pre-EclampsiaType 2 DiabetesHypertensionAnemiaAnemia of PregnancyGestational DiabetesGestational Hypertension
- Interventions
- Other: SMARThealth Pregnancy
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 3240
- Registration Number
- NCT05752955
- Locations
- 🇮🇳
The George Institute for Global Health, Hyderabad, Telangana, India
Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
- Conditions
- Diabetic Ketoacidosis
- Interventions
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 680
- Registration Number
- NCT05752279
- Locations
- 🇦🇺
Royal North Shore Hospital, St Leonards, New South Wales, Australia
🇦🇺Redcliffe Hospital, Redcliffe, Queensland, Australia
PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care
- Conditions
- Acute Kidney Injury
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-07-21
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 3000
- Registration Number
- NCT05468203
- Locations
- 🇦🇺
Grampians Health, Ballarat, Victoria, Australia
🇦🇺Austin Health, Heidelberg, Victoria, Australia
TESTING -ON Post-Trial ObservatioNal Cohort Study
- Conditions
- ESRDGlomerulonephritisKidney DiseasesIgA Nephropathy
- First Posted Date
- 2022-06-28
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 366
- Registration Number
- NCT05434325
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇨🇦University of Calgary/Alberta Health Services, Calgary, Alberta, Canada
🇨🇦University of Alberta Hospitals, Edmonton, Alberta, Canada
The RAFT ECT Study
- Conditions
- Major Depressive Episode
- Interventions
- Procedure: Temporoparietal Ultrabrief Right Unilateral (UBRUL-TP) electroconvulsive therapyProcedure: Frontoparietal Ultrabrief Right Unilateral (UBRUL-FP) electroconvulsive therapy
- First Posted Date
- 2022-06-02
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 154
- Registration Number
- NCT05402657
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
🇦🇺Ramsay Clinic Northside, Sydney, New South Wales, Australia
🇦🇺Ramsay Clinic Lakeside, Warners Bay, New South Wales, Australia
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
- First Posted Date
- 2022-05-05
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 80
- Registration Number
- NCT05363397
- Locations
- 🇦🇺
Timothy Ang, Camperdown, New South Wales, Australia
🇦🇺Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺Royal Melbourne Hospital, Parkville, Victoria, Australia
SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
- First Posted Date
- 2022-04-25
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 994
- Registration Number
- NCT05345327
- Locations
- 🇦🇺
The George Institute for Global Health, Brisbane, Queensland, Australia
🇦🇺Monash University, Melbourne, Victoria, Australia
🇱🇰Kandy National Hospital, Kandy, Sri Lanka
Polydiuretic Therapy for HFpEF, a Randomised Controlled Trial
- Conditions
- Heart Failure With Preserved Ejection Fraction
- Interventions
- Drug: Low dose combination polydiuretic therapy
- First Posted Date
- 2021-11-22
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 3
- Registration Number
- NCT05129722
- Locations
- 🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia
Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy
- Conditions
- Neurocognitive Impairment, Mild
- Interventions
- Other: Standard Care
- First Posted Date
- 2021-05-27
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 190
- Registration Number
- NCT04904536
- Locations
- 🇦🇺
The George Institute for Global Health, Sydney, New South Wales, Australia